As health information technology (HIT) continues to grow and change the face of healthcare, investors are taking note. Private equity and venture capital firms are increasingly investing in up-and-coming HIT and mobile medical app companies, and larger companies are looking to innovate through acquisitions of HIT businesses. But these investments raise unique questions and require specialized due diligence. When acquiring a medical app company, are you buying the company, its technology or its data? If it includes the latter, who owns the data? Can the seller transfer data that may contain protected health information? What consents are in place? What notices are required? This session will use a hypothetical mobile medical app acquisition to examine the due diligence considerations of HIT investment. The speakers will look at the risks, challenges and regulatory considerations from both the seller’s and buyer’s perspective, as well as solutions and best practices.
Identify the unique data rights, intellectual property, privacy and security, and regulatory concerns associated with mergers and acquisitions involving health information
Demonstrate data mapping analysis to show how data is collected, used, stored, transferred and destroyed, and how data rights may impact a transaction
Demonstrate an approach to evaluating an application’s architecture in the data review process and the degree to which it is standards-based, a critical factor for scalability, interoperability and privacy and security
Explain solutions for startups throughout the data lifecycle to facilitate increased valuations, as well as discussing red flags for investors that could impact a deal